Ex-BioNTech strategy chief Ryan Richardson launches Bios Life, a $25M-backed virtual cancer surveillance startup
BioNTech’s former chief strategy officer Ryan Richardson had a front seat to the creation of a Covid vaccine, and then helped orchestrate BioNTech’s return to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Bios Life has emerged from stealth with $25m and a Tempus data alliance to build continuous, AI-driven cancer surveillance for…
RQ Bio has clinched $115 million in a Series A raise to advance a preclinical pipeline of virus-targeting antibodies.
New York City-based startup Waypoint Bio has raised $20 million in series A financing to test multiple cell therapies in China.
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a
Radical Health just emerged from stealth, having raised $5 million in pre-seed funding led by Khosla Ventures.
Dash Bio raises $30M Series A led by Oak HC/FT. Co-founded by ex-Moderna exec Dave Johnson, the Waltham, MA startup offers…
